NCT06056583View on ClinicalTrials.gov

Drug Excretion in Breast Milk

PHASE4RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 4, 2023

Primary Completion Date

September 30, 2028

Study Completion Date

September 30, 2028

Conditions
PostpartumLactationDrugs in Breast MilkMammary Drug TransportersBCRPOCT1
Interventions
DRUG

Cimetidine 200 MG

Cimetidine will serve as the probe drug

Trial Locations (1)

98195

RECRUITING

University of Washington, Seattle

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

University of Washington

OTHER